Finasteride: Uses, Dosage & Side Effects

10 min read

Quick Facts

What Is Finasteride?

Finasteride is a selective inhibitor of type II 5-alpha reductase, an enzyme that converts testosterone to its more potent metabolite, dihydrotestosterone (DHT). It reduces DHT levels in prostate and scalp tissue.

How Finasteride Works
By inhibiting 5-alpha reductase, finasteride decreases DHT production by approximately 70%, reducing prostate size and slowing hair loss. Effects develop gradually over 3-12 months.

Indications

Benign Prostatic Hyperplasia (5 mg):

  • Moderate-to-severe lower urinary tract symptoms
  • Urinary retention
  • Recurrent urinary tract infections
  • Hematuria due to BPH

Male Pattern Hair Loss (1 mg):

  • Androgenetic alopecia vertex and anterior midscalp
  • Prevention of further hair loss progression
  • Not effective for frontal alopecia in all patients

Dosage and Administration

BPH:

  • 5 mg once daily (Proscar)
  • Take with or without food
  • Maximum effect: 6-12 months of continuous therapy

Hair Loss:

  • 1 mg once daily (Propecia)
  • Take with or without food
  • Discontinuation results in hair loss regression within 3-12 months
Clinical Note
Finasteride reduces PSA levels by approximately 50%. A baseline PSA is recommended for prostate cancer screening purposes. Women of childbearing potential should not handle or be exposed to crushed finasteride tablets due to teratogenic risk.

Side Effects

Common: Erectile dysfunction (2-7%), decreased libido, ejaculatory dysfunction, gynecomastia Rare: Depression, anxiety, persistent sexual dysfunction after discontinuation

Contraindications

  • Pregnancy or women of childbearing potential
  • Hypersensitivity to finasteride
  • Pediatric use (not indicated)
  • Children exposed to finasteride (through handling or exposure)

Drug Interactions

  • Minimal significant interactions
  • May interact with strong CYP3A4 inhibitors (theoretically)
  • No interactions with common cardiovascular medications

Key Clinical Evidence

PLESS trial (NEJM 1998) demonstrated 31% reduction in prostate volume and improvement in symptom scores over 4 years. PROPECIA trial showed 66% of men experienced stabilization or improvement in hair loss. Combination with alpha-blockers provides superior symptom improvement in BPH.

Monitoring Parameters

  • Baseline assessment before initiating therapy
  • Regular clinical follow-up per indication
  • Laboratory parameters as specified in sections above
  • Drug interaction screening at each visit

Special Populations

Dosing adjustments may be necessary in:

  • Renal impairment
  • Hepatic impairment
  • Elderly patients
  • Pregnancy and lactation
  • Pediatric patients

Patient Counseling

  • Take exactly as directed; do not modify dose without consulting healthcare provider
  • Report any unusual symptoms or adverse effects
  • Maintain regular follow-up appointments
  • Store at room temperature away from moisture and light
  • Keep out of reach of children

Disclaimer: This information is for educational purposes only and should not substitute for professional medical advice. Always consult with a qualified healthcare provider before starting, stopping, or modifying any medication.

Sources

  1. [1]undefined. "PubMed Reference." undefined, undefined.
  2. [2]undefined. "PubMed Reference." undefined, undefined.

Medically reviewed by

,

Last updated: 2024-01-01Sources: 2

The content on Medical Atlas is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.